AI accelerates leukemia cell detection

Description

For many patients with acute myeloid leukemia (AML), the disease unfortunately returns after initially successful treatment. Amsterdam UMC has been a leader for 25 years in developing sensitive methods to detect residual leukemia cells. With artificial intelligence (AI), this can now be done just as accurately, yet much faster.